An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions

Dose 1 and Dose 2

"* Period 2 (itraconazole administration only).~* Period 3 (AZD0780 + itraconazole administration)."

"* Period 2 (carbamazepine administration only).~* Period 3 (AZD0780 + carbamazepine administration only)."

"* Period 1 (midazolam administration only).~* Period 3 (AZD0780 + midazolam administration)."

"* Period 1 (EE and LNG administration only).~* Period 3 (AZD0780 + EE and LNG administration)."